Infant DeathInfant CareMidwiferyEducationAccident at Home
Investigational drug(s) / intervention(s)
Education
Education: The educational content consists of general information about sudden infant death syndrome and home accidents in children aged 0-3, as well as prevention methods.
Study summary
This project is a pioneering study in determining the impact of midwife-led safe infant care training for pregnant women on awareness of sudden infant death syndrome (SIDS) and home accidents. Raising awareness and improving women's knowledge about SIDS and home accidents is expected to help reduce preventable infant deaths. If the effectiveness of this training is proven, integrating it into prenatal care programs would be a significant step towards improving maternal and child health.
Eligibility
Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Volunteering to participate in the research
* Being able to speak and understand Turkish
* Being literate
* Being a primiparous pregnant woman (due to the greater need for information) ≥36th week of pregnancy (because it is close to delivery and there is sufficient time to translate what they have learned into behavior)
Exclusion Criteria:
* Diagnosed high-risk pregnancy
* Diagnosed mental health condition
* Having previously received training/course in safe infant care
Primary outcome measure(s)
Home Accident Awareness Scale for Mothers — pre-intervention, immediately after the intervention, after 2 week Items are scored on a scale of 1-5. As the scale score increases, mothers' awareness of household accidents will increase.
Sudden Infant Death Syndrome Awareness Scale - Mother Form — pre-intervention, immediately after the intervention, after 2 week Items are scored on a scale of 1 to 5. As the score obtained from the scale increases, the awareness score decreases.
Trial sites (1)
Facility
City
Region
Status
Cukurova University Faculty of Health Sciences Department of Midwifery
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.